Jubilant Organosys Ltd. Looks For $40M To Develop Molecules

Venturewire -- Jubilant Organosys Ltd., a pharmaceutical company partly owned by General Atlantic LLC, is thinking about raising dozens of millions of dollars to form separate entities that will develop molecules used to make drugs....